Kawasaki disease

British Journal of Hospital Medicine

Volumn 55, Issue 1-2, 1996, Pages 9-14

  Samuel, Jacob ^a   O'Sullivan, John ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN;

ANTIBODY PRODUCTION; B LYMPHOCYTE; CELLULAR IMMUNITY; CHILD; CORONARY ARTERY DISEASE; FEMALE; HUMAN; IMMUNOLOGY; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; REVIEW; T LYMPHOCYTE;

ANTIBODY FORMATION; ANTIGENS; B-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; CORONARY DISEASE; FEMALE; HUMANS; IMMUNITY, CELLULAR; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; T-LYMPHOCYTES;

EID: 0030591032     PISSN: 00071064     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Akagi T, Rose V, Benson LN, Newman A, Freedom RM (1992) Outcome of coronary artery aneurysms after Kawasaki disease./ Pediatr 121(5): 689-94
2. Bum DM, Pollack P, Bianco JA (1986) Intravenous streptokmase in an infant with Kawasaki's disease complicated by acute myocardial infarction. Pediatr Cardiol 6: 307-11
3. Dajani AS, Taubert KA, Takahashi M et al (1994) Guidelines for long term management of patients with Kawasaki disease. Circulation 89(2): 916-22
4. Fujita Y, Nakamura Y, Sakata K et al (1989) Kawasaki disease in families. Pediatrics 84: 666-9
5. Furusho K, Kamiya T, Nakano H et al (1984) High dose intravenous gammaglobulin for Kawasaki disease. Lancet ii: 1055-8
6. Gidding SS, Shulman ST (1994) Diagnosis and management of children with Kawasaki disease. Heart Dis Stroke 3(4): 210-15
7. Ishiwata S, Fuse K, Nishiyama S, Nakanishi S, Watanabe Y, Seki A H 992) Adult coronary disease secondary to Kawasaki disease in childhood. Am J Cardiol 69: 692-4
8. Kato H, Fugimoto Y, Inoue E et al (1983) Variant strain of Propionibacterium acnes: a clue to the aetiology of Kawasaki disease. Lancet ii: 1383-7
9. Kato H, Inoue O, Kawasaki T, Fujiawara H, Watanabe T, Toshima H (1992) Adult coronary artery disease probably due to childhood Kawasaki disease. Lancet 340: 1127-9
10. Kawasaki T (1991) Kawasaki disease. Cardiology in the Young 1:184-91
11. Leung DYM, Meissner HC, Fulton DR, Murrey DL, Kotzin BL, Schlievert PM (1993) Toxic shock syndrome toxin secreting staphylococcus in Kawasaki syndrome. Lancet 342: 1385-7
12. Mason WH, Schneider T, Takahashi M (1991) The epidemiology and aetiology of Kawasaki disease. Cardiology in the Young 1: 196-205
13. Morens DM, Anderson LJ, Hurwitz ES (1980) National surveillance of Kawasaki disease. Pediatrics 65: 21-5
14. Naoe S, Shibuya K, Takahashi K, Wakayama M, Masuda H, Tanaka M (1991) Pathological observations concerning the cardiovascular lesions in Kawasaki disease. Cardiology in the Young 1: 212-20
15. Newburger JW, Burns JC (1989) Kawasaki syndrome. Cardiol Clin 7: 453-65
16. Newburger JW, Takahashi M, Burns J et al (1986) The treatment of Kawasaki disease with intravenous gammaglobulin. N EnelJMed3ï5: 341-7
17. Newburger JW, Takahashi M, Beiser AS et al (1991) A single intravenous infusion of gammaglobulin as compared to four doses in the treatment of acute Kawasaki syndrome. TV Engl J Med 324: 1633-9
18. Paridon SM, Galioto FM, Vincent JA, Tomassoni TL, Sullivan NM, Bricker JT (1995) Exercise capacity and incidence of myocardial perfusion defect after Kawasaki disease in children and adolescents. J Am Coll Cardiol 25(6): 1420-3
19. Ross B (1995) Kawasaki disease: unsafe at any age? J Am Coll Cardiol 25(6): 1425-7
20. Rowley AH, Shulman ST (1991) Current therapy for acute Kawasaki syndrome. J Pediatr 118(6): 987-91
21. Rowley A, Duffy C, Shulman S (1988) Prevention of giant coronary artery aneurysms in Kawasaki disease by intravenous gammaglobulin therapy. J Pediatr 113(2): 290-3
22. Suzuki A, Tizard EJ, Gooch V, Dillon MJ, Haworth SG (1990) Kawasaki disease: echocardiographic changes in 91 cases presenting in the United Kingdom. Arch Dis Child 65(10): 1142-6